ENZYVANT Trademark

Trademark Overview


On Thursday, March 28, 2019, a trademark application was filed for ENZYVANT with the United States Patent and Trademark Office. The USPTO has given the ENZYVANT trademark a serial number of 88361384. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by Enzyvant Therapeutics GmbH. The ENZYVANT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto

Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials

(Based on 44(e)) Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
enzyvant

General Information


Serial Number88361384
Word MarkENZYVANT
Filing DateThursday, March 28, 2019
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6077704
Registration DateTuesday, June 16, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
Goods and ServicesScientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials
Goods and Services(Based on 44(e)) Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnzyvant Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameEnzyvant Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameEnzyvant Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 27, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 7, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 26, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, January 25, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, January 25, 2020FINAL REFUSAL E-MAILED
Saturday, January 25, 2020FINAL REFUSAL WRITTEN
Thursday, November 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Saturday, May 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 18, 2019NON-FINAL ACTION E-MAILED
Saturday, May 18, 2019NON-FINAL ACTION WRITTEN
Thursday, May 9, 2019ASSIGNED TO EXAMINER
Tuesday, April 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 1, 2019NEW APPLICATION ENTERED IN TRAM